P.17.4 DOWNSTAGING THERAPY IN PATIENTS WITH INTERMEDIATE STAGE HCC (BCLC B) AS BRIDGE FOR TRANSPLANTATION: THE HEPATOCATT EXPERIENCE
2014; Elsevier BV; Volume: 46; Linguagem: Inglês
10.1016/s1590-8658(14)60359-5
ISSN1878-3562
AutoresT.A. Di Rienzo, V. Cesario, M. Campanale, Maria Grazia D’Angelo, Federico Barbaro, F. D’Aversa, M. Siciliano, B.E. Annicchiarico, Maurizio Pompili, Antonio Grieco, G.L. Rapaccini, S. Akila Agnes, A.W. Avolio, Roberto Iezzi, Anna Maria De Gaetano, Giovanni Battista Gasbarrini, Antonio Gasbarrini, S.G. Hepatocatt,
Tópico(s)Gallbladder and Bile Duct Disorders
Resumoof Digestive Diseases / Digestive and Liver Disease 46S (2014) S1-S144 S121 the follow-up (median 27.5 months, range 3-156) one case of tumor seeding along the needle tract (2.2%) occurred: the neoplastic implant was surgically removed and the patients died after 13 years following initial ablation.Local tumor progression was observed in 6 cases (12%).Conclusions: Direct puncture of subcapsular HCC nodules up to 4 cm with either RF cool-tip needles or MW antennas proved to be a safe and effective procedure.Quick and steady insertion of the needle, rapid onset of coagulation and the intra-abdominal postive pressure are likely factors explaining negligible trauma to subcapsular lesions and lack of hemorrhagic complications.In turn, the needle track ablation properly performed in all cases makes unlikely tumor seeding.P.17.
Referência(s)